What is the challenge?
There are over 50 million people worldwide living with dementia and by 2030 this number is expected to reach 82 million.
The ageing brain becomes vulnerable to decline and keeping independency in daily life can become a challenge for the elderly. People with Mild Cognitive Impairment (MCI), an intermediate condition between normal brain ageing and dementia, may develop dementia in the future.
There is an urgent need for early risk assessment and intervention. Current practices with time-consuming patient investigations focus on late symptoms management due to a lack of diagnostic tools. This causes numerous implications in terms of familial, medical and care costs.
With AI-Mind we aim to reduce the disease’s burden by developing novel, AI-based tools to support healthcare professionals in their diagnosis and offering timely interventions to patients.
At the heart of AI-Mind is our research study, that
Takes place in Norway, Finland, Italy and Spain and will involve 1,000 participants.
Helps to develop and validate artificial intelligence (AI) based tools to predict who is likely to develop dementia.
Visit our local study pages to learn more
Go to AI-Mind Share
A space designed to share valuable insights from the AI-Mind project and our research. Here, you will find resources on dementia research, MCI diagnosis, AI in healthcare, data privacy, and more.
Click hereLatest news below

AI-Mind Share: A Knowledge Hub for Raising Awareness and Sharing Dementia Research
AI-Mind Share: A Knowledge Hub for Raising Awareness and Sharing Dementia Research To mark Brain

Norway: Banebrytende KI-teknologi kan gi revolusjonere demensomsorgen – men kommunene mangler penger
Banebrytende KI-teknologi kan gi revolusjonere demensomsorgen – men kommunene mangler penger Flere kommuner ønsker å
AI-Mind
-
External advisors from ethics, neuroscience, AI, modelling and economics
-
Advocacy groups for patients and physicians
